中東およびアフリカの動物およびヒト用ワクチン市場、タイプ別(ヒトおよび動物)、エンドユーザー別(病院、診療所、その他)、流通チャネル別(直接入札、小売販売、その他) - 2031 年までの業界動向および予測。
中東およびアフリカの動物およびヒトワクチン市場の分析と洞察
感染症の蔓延は世界中で増加しており、インフルエンザや細菌感染症が急速に増加していることが分かっており、これが市場の成長を後押ししています。注射部位の発赤、痛み、腫れなどの軽度の副作用にはアレルギー反応が含まれる可能性があり、その反応は非常にまれであるため、市場の成長に影響を与えることが予想されます。
データブリッジマーケットリサーチの分析によると、中東およびアフリカの動物およびヒト用ワクチン市場は、2023年の3,480,103.50千米ドルから2031年には5,358,452.80千米ドルに達し、2024年から2031年の予測期間に5.6%のCAGRで成長すると予想されています。
レポートメトリック |
詳細 |
予測期間 |
2024年から2031年 |
基準年 |
2023 |
歴史的な年 |
2022 (2016~2021年にカスタマイズ可能) |
定量単位 |
収益(千米ドル) |
対象セグメント |
タイプ(人間と動物)、エンドユーザー(病院、診療所、その他)、流通チャネル(直接入札、小売販売、その他) |
対象国 |
サウジアラビア、エジプト、UAE、イスラエル、イラン、イラク、オマーン、クウェート、カタール、バーレーン、イエメン、ヨルダン、レバノン、パレスチナ、中東のその他の地域、南アフリカ、ナイジェリア、エチオピア、タンザニア、ケニア、アルジェリア、ガーナ、モザンビーク、ウガンダ、コンゴ民主共和国、スーダン、モロッコ、アンゴラ、マダガスカル、マラウイ、ザンビア、コートジボワール、カメルーン、ジンバブエ、リビア、チャド、ボツワナ、ナミビア、レソト、モーリシャス、エスワティニ、コモロ、セイシェル、およびその他のアフリカ諸国 |
対象となる市場プレーヤー |
GSK plc.、Merck & Co., Inc.、Sanofi、Boehringer Ingelheim International GmbH、Ceva、ONDERSTEPOORT BIOLOGICAL PRODUCTS SOC (PTY) LTD、MCI Santé Animale、Biogénesis Bagó、HESTER BIOSCIENCES LIMITED など |
市場の定義
ワクチンは、特定の病気に対する免疫を誘発するために、個々の免疫系を刺激する製品です。ワクチンは記憶と認識の原理に基づいて機能します。弱毒化または殺菌された微生物を体内に注入すると、これらの微生物は免疫系の記憶細胞であるB細胞に病原体を認識させ、将来同じ病原体が体を攻撃した場合、それらに対抗します。肺炎球菌感染症、麻疹、おたふく風邪、風疹、肝炎、インフルエンザ、腸チフス、水痘、狂犬病など、世界中で蔓延しているいくつかの種類の感染症に対するワクチンが発見されています。
中東およびアフリカの動物およびヒトワクチン市場の動向
このセクションでは、市場の推進要因、機会、課題、制約について理解します。これらについては、以下で詳しく説明します。
ドライバー
- 予防接種プログラムとキャンペーンの拡大
中東およびアフリカ諸国で強力な予防接種プログラムを実施することは、公衆衛生の向上と感染症の蔓延防止に不可欠です。このような取り組みを成功させるには、包括的な啓発キャンペーンを実施することが不可欠です。慢性疾患の増加により、予防接種プログラムとキャンペーンが世界中で増加しています。肝炎、ジフテリア、百日咳、ポリオなどの感染症が環境中に蔓延しているため、いくつかのキャンペーンとプログラムを立ち上げることでワクチン接種に関する啓発を緊急に高める必要があります。感染症の増加に伴い、予防接種プログラムの数も増加していると報告されています。これに伴い、衰弱性疾患と闘う目的で予防接種の範囲も世界中で拡大しています。
- 慢性疾患の増加
感染症の蔓延は世界中で増加しており、インフルエンザや細菌感染症が急速に増加しています。感染症の増加率により、ワクチン接種や免疫接種によって予防できる病気の予防が必要になっています。病気がかなりの割合で増加しているため、集団ワクチン接種が緊急に必要とされています。集団ワクチン接種には大量のワクチンが必要なため、市場に大きな成長をもたらすことが期待されています。慢性疾患が世界中で増加しているため、ワクチンの需要が大幅に高まり、ワクチン市場が拡大しています。この健康上の課題の拡大に対応して、さまざまな慢性疾患の発生率と重症度を軽減する上でワクチンが果たす予防的役割に対する認識が高まっています。
機会
- 市場参加者による戦略的開始と意思決定
ワクチン市場の市場プレーヤーは、拡大、コラボレーション、買収など、さまざまな戦略的イニシアチブを採用しています。これらのイニシアチブにより、企業の製品ポートフォリオが拡大し、市場が拡大し、顧客の間で製品需要が高まり、最終的に市場プレーヤーは最大の収益を得ることができます。重要な側面の 1 つは、新たな健康上の脅威に対処する新しいワクチンを革新して導入するための研究開発への継続的な投資です。研究機関、政府機関、中東およびアフリカの保健機関とのコラボレーションは、集合的な専門知識とリソースを活用するのに役立ちます。
効果的で新しいワクチンの需要が世界中で高まる中、これらの戦略的取り組みは、事業運営を強化し、市場での収益性を高めることを目的として、トップの市場プレーヤーによって実施されています。
制約/課題
- 登録されたワクチンが市場で入手できない
登録済みワクチンが入手できない原因としては、厳格な規制承認とワクチン開発に時間のかかる手順が挙げられます。登録済みワクチンが入手できないことは公衆衛生に重大な影響を及ぼし、疾病予防と管理に課題をもたらします。ワクチンが入手できないと、感染症に対する脆弱性が高まり、集団発生の可能性があり、国民に深刻な健康被害をもたらすリスクが高まります。登録済みワクチンが入手できない問題に対処するには、規制機関、製薬会社、医療制度の取り組みを組み合わせる必要があります。規制当局は、ワクチンの評価、認可、管理、監視に困難を感じています。これらの規制により、ワクチンの世界的供給が遅れています。
- ワクチン接種による有害な副作用
ワクチンは医薬品であり、さまざまな病気の予防に役立ちます。しかし、ワクチンの使用により副作用が発生することがあります。その一部は、注射部位の発赤、痛み、腫れなどの軽度の副作用です。ワクチンの副作用の大部分は軽度で一時的なものであり、重篤な病気を予防するワクチン接種のメリットはリスクをはるかに上回ります。これにはアレルギー反応が含まれますが、重篤なアレルギー反応は非常にまれです。さらに、あらゆる医療介入と同様に、ワクチンにはギランバレー症候群 (GBS) や血栓症などのまれではありますが重篤な副作用が生じる可能性があります。ただし、ワクチンの有害な副作用はまれですが、生命を脅かすものです。
最近の動向
- 2023年1月、ベーリンガーインゲルハイムの最新のイノベーションであるSenvelgoが、名誉あるアニマルヘルス・コンパニオンアニマルズ最優秀新製品賞を受賞しました。この賞は、糖尿病の猫の治療を簡素化し、改善することにSenvelgoが顕著に貢献したことを表彰するものです。ベーリンガーインゲルハイムのイノベーションへの取り組みはSenvelgoに表れており、シンプルで安全であるだけでなく、猫の患者とその介護者の両方にとって非常に便利なソリューションを提供しています。
- 2023年、メルク社は米国食品医薬品局(FDA)から、FIGO 2014ステージIII-IVA子宮頸がん患者の治療に、抗PD-1療法であるKEYTRUDAを化学放射線療法(CRT)と併用する承認を取得しました。この承認は、第3相KEYNOTE-A18試験の肯定的な結果に基づいています。この試験では、KEYTRUDAとCRTの併用により、プラセボとCRTの併用と比較して、病気の進行または死亡のリスクが41%減少しました。無増悪生存期間(PFS)の中央値は、どちらのグループでも達成されませんでした。これは、子宮頸がんにおけるKEYTRUDAの3番目の適応症であり、その有効性を強調するものであり、米国におけるKEYTRUDAの全体で39番目の適応症です。このマイルストーンは、さまざまな種類のがん患者の治療オプションを前進させるというメルクの取り組みを強調しています。
- 2023年7月、バイオジェネシス・バゴは国連食糧農業機関(FAO)の下でバイオアフトーゲンを発表しました。これは、バイオアフトーゲンがこのような事前認定を受けた最初の口蹄疫ワクチンとなる歴史的な瞬間です。この成果は、口蹄疫予防における世界的リーダーとしての同社の地位を強化し、主要な技術・科学組織との協力への取り組みを強化し、世界中の食品の安全性と動物の健康状態に貢献します。
- 2020年11月、GSK plc.はMedicines for Malaria Ventureと共同で、小児および青少年の三日熱マラリア治療に使用されるタフェノキンの肯定的なデータ(TEACH研究)を発表しました。4か月の検査中、研究の被験者60人のうち95%に三日熱マラリアの兆候は見られませんでした。結果は、2020年アメリカ熱帯医学衛生学会のバーチャル年次総会で発表されました。これにより、同社はマラリア治療薬の開発を進め、製品の証拠を提供することができました。
- 2020年11月、サノフィは、18歳以上の成人のインフルエンザ疾患の予防を目的としたSupemtek(四価組換えインフルエンザワクチン)の欧州委員会からの承認を取得しました。この承認により、同社はワクチンを含む製品ポートフォリオを前進させ、欧州のワクチン市場における基盤を強化することができました。
中東およびアフリカの動物およびヒトワクチン市場の範囲
中東およびアフリカの動物およびヒト用ワクチン市場は、タイプ、エンドユーザー、流通チャネルに基づいて 3 つの主要なセグメントに分類されます。セグメント間の成長は、ニッチな成長分野と市場へのアプローチ戦略を分析し、コア アプリケーション領域とターゲット市場の違いを判断するのに役立ちます。
タイプ
- 人間
- 動物
タイプに基づいて、中東およびアフリカの動物およびヒトワクチン市場は、ヒトと動物に分類されます。
エンドユーザー
- 病院
- クリニック
- その他
エンドユーザーに基づいて、中東およびアフリカの動物およびヒト用ワクチン市場は、病院、診療所、その他に分類されます。
流通チャネル
- 直接入札
- 小売販売
- その他
流通チャネルに基づいて、中東およびアフリカの動物およびヒトワクチン市場は、直接入札、小売販売、その他に分類されます。
中東およびアフリカの動物およびヒトワクチン市場の地域分析/洞察
中東およびアフリカの動物およびワクチン市場は、タイプ、エンドユーザー、流通チャネルの 3 つの主要なセグメントに分類されます。
この市場レポートの対象国は、サウジアラビア、エジプト、UAE、イスラエル、イラン、イラク、オマーン、クウェート、カタール、バーレーン、イエメン、ヨルダン、レバノン、パレスチナ、中東のその他の地域、南アフリカ、ナイジェリア、エチオピア、タンザニアです。 、ケニア、アルジェリア、ガーナ、モザンビーク、ウガンダ、コンゴ民主共和国、スーダン、モロッコ、アンゴラ、マダガスカル、マラウイ、ザンビア、コートジボワール、カメルーン、ジンバブエ、リビア、チャド、ボツワナ、ナミビア、レソト、モーリシャス、エスワティニ、コモロ、セイシェル、その他のアフリカ諸国。
南アフリカは、同国における政府支援と資金提供の増加により、アフリカの動物およびワクチン市場を支配すると予想されています。サウジアラビアは、予防接種プログラムとキャンペーンの増加により、中東の動物およびワクチン市場を支配すると予想されています。
レポートの国別セクションでは、市場の現在および将来の傾向に影響を与える国内市場における個別の市場影響要因と規制の変更も提供しています。新規販売、交換販売、国の人口統計、規制行為、輸出入関税などのデータ ポイントは、各国の市場シナリオを予測するために使用される主要な指標の一部です。また、国別データの予測分析を提供する際には、地域ブランドの存在と可用性、地元および国内ブランドとの競争が激しいか少ないために直面する課題、販売チャネルの影響も考慮されます。
中東およびアフリカの動物およびヒトワクチン市場の競争環境とシェア分析
中東およびアフリカの動物およびヒト用ワクチン市場の競争状況では、競合他社ごとに詳細が提供されます。詳細には、会社概要、会社の財務状況、収益、市場の可能性、研究開発への投資、新しい市場への取り組み、生産拠点と施設、会社の強みと弱み、製品の発売、製品の承認、製品の幅と幅、アプリケーションの優位性、製品タイプのライフライン曲線が含まれます。上記のデータ ポイントは、中東およびアフリカの動物およびヒト用ワクチン市場への会社の重点にのみ関連しています。
中東およびアフリカの動物およびヒト用ワクチン市場で事業を展開している主要企業としては、GSK plc.、Merck & Co., Inc.、Sanofi、Boehringer Ingelheim International GmbH、Ceva、ONDERSTEPOORT BIOLOGICAL PRODUCTS SOC (PTY) LTD、MCI Santé Animale、Biogénesis Bagó、HESTER BIOSCIENCES LIMITED などがあります。
SKU-
世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする
- インタラクティブなデータ分析ダッシュボード
- 成長の可能性が高い機会のための企業分析ダッシュボード
- カスタマイズとクエリのためのリサーチアナリストアクセス
- インタラクティブなダッシュボードによる競合分析
- 最新ニュース、更新情報、トレンド分析
- 包括的な競合追跡のためのベンチマーク分析のパワーを活用
目次
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE MIDDLE EAST AND AFRICA ANIMAL AND HUMAN VACCINES MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER’S FIVE FORCES
5 REGULATORY SCENARIO
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 GROWING IMMUNIZATION PROGRAMS AND CAMPAIGNS
6.1.2 GROWING PREVALENCE OF CHRONIC CONDITIONS
6.1.3 PRODUCTION OF NEW VACCINES IN THE HEALTHCARE MARKET
6.1.4 INCREASING GOVERNMENT SUPPORT AND FUNDING
6.2 RESTRAINTS
6.2.1 UNAVAILABILITY OF REGISTERED VACCINES IN THE MARKET
6.2.2 HIGH COST AND DIFFERENCES IN PRICING OF THE VACCINES
6.3 OPPORTUNITIES
6.3.1 STRATEGIC INITIATION AND DECISION TAKEN BY THE MARKET PLAYERS
6.3.2 RISING PREVALENCE OF PIPELINE PRODUCTS
6.3.3 EMPHASIZING THE ROLE OF VACCINATION IN INDIVIDUAL AND COMMUNITY
6.4 CHALLENGES
6.4.1 HARMFUL SIDE EFFECTS CAUSED BY VACCINATION
6.4.2 FEAR AMONG PATIENTS RELATED TO INJECTIONS AND NEEDLE STICKS
7 MIDDLE EAST AND AFRICA ANIMAL AND HUMAN VACCINES MARKET, BY TYPE
7.1 OVERVIEW
7.2 HUMAN
7.2.1 HUMAN PAPILLOMAVIRUS (HPV)
7.2.1.1 CERVICAL CANCER
7.2.1.2 OROPHARYNGEAL CANCER
7.2.1.3 ANAL CANCER
7.2.1.4 VULVAR AND VAGINAL CANCER
7.2.1.5 PENILE CANCER
7.2.1.6 OTHERS
7.2.2 PNEUMOCOCCAL VACCINE (PCV)
7.2.3 DTAP VACCINE
7.2.4 ROTAVIRUS VACCINE
7.2.5 INFLUENZA VACCINE
7.2.6 OTHERS
7.3 ANIMAL
7.3.1 BRUCELLOSIS
7.3.1.1 LIVE
7.3.1.2 INACTIVATED
7.3.1.2.1 CATTLE
7.3.1.2.2 CAPRINE
7.3.1.2.3 OVINE
7.3.2 FOOT AND MOUTH
7.3.2.1 INACTIVATED
7.3.2.2 LIVE
7.3.2.2.1 CATTLE
7.3.2.2.2 SHEEP AND GOAT
7.3.2.2.3 PIGS
7.3.2.2.4 OTHERS
7.3.3 AFRICAN HORSE SICKNESS
7.3.3.1 LIVE
7.3.3.2 INACTIVATED
7.3.3.2.1 HORSE
7.3.3.2.2 DONKEY
7.3.3.2.3 MULES
7.3.4 RIFT VALLEY FEVER
7.3.4.1 LIVE
7.3.4.2 INACTIVATED
7.3.4.2.1 SMITHBURN STRAIN BASED VACCINE
7.3.4.2.2 ALUMINUM HYDROXIDE GEL AS ADJUVANT BASED VACCINE
7.3.4.2.3 Others
8 MIDDLE EAST AND AFRICA ANIMAL AND HUMAN VACCINES MARKET, BY END USER
8.1 OVERVIEW
8.2 HOSPITAL
8.2.1 HUMAN HOSPITALS
8.2.2 VETERINARY HOSPITALS
8.3 CLINICS
8.3.1 SPECIALTY CLINICS
8.3.2 VETERINARY CLINICS
8.4 OTHERS
8.4.1 ANIMAL HUSBANDRY
8.4.2 PET SHOPS
8.4.3 OTHERS
9 MIDDLE EAST AND AFRICA ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL
9.1 OVERVIEW
9.2 DIRECT TENDERS
9.3 RETAIL SALES
9.4 OTHERS
10 MIDDLE EAST & AFRICA ANIMAL AND HUMAN VACCINES MARKET, BY COUNTRY
10.1 MIDDLE EAST & AFRICA
10.2 MIDDLE EAST
10.2.1 SAUDI ARABIA
10.2.2 EGYPT
10.2.3 U.A.E.
10.2.4 ISRAEL
10.2.5 IRAN
10.2.6 IRAQ
10.2.7 OMAN
10.2.8 KUWAIT
10.2.9 QATAR
10.2.10 BAHRAIN
10.2.11 YEMEN
10.2.12 JORDAN
10.2.13 LEBANON
10.2.14 PALESTINE
10.2.15 REST OF MIDDLE EAST
10.3 AFRICA
10.3.1 SOUTH AFRICA
10.3.2 NIGERIA
10.3.3 ETHIOPIA
10.3.4 TANZANIA
10.3.5 KENYA
10.3.6 ALGERIA
10.3.7 GHANA
10.3.8 MOZAMBIQUE
10.3.9 UGANDA
10.3.10 DEMOCRATIC REPUBLIC OF CONGO
10.3.11 SUDAN
10.3.12 MOROCCO
10.3.13 ANGOLA
10.3.14 MADAGASCAR
10.3.15 MALAWI
10.3.16 ZAMBIA
10.3.17 IVORY COAST
10.3.18 CAMEROON
10.3.19 ZIMBABWE
10.3.20 LIBYA
10.3.21 CHAD
10.3.22 BOTSWANA
10.3.23 NAMIBIA
10.3.24 LESOTHO
10.3.25 MAURITIUS
10.3.26 ESWATINI
10.3.27 COMOROS
10.3.28 SEYCHELLES
10.3.29 REST OF AFRICA
11 MIDDLE EAST AND AFRICA ANIMAL AND HUMAN VACCINES MARKET, COMPANY LANDSCAPE
11.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA
12 SWOT ANALYSIS
13 COMPANY PROFILES
13.1 GSK PLC.
13.1.1 COMPANY SNAPSHOT
13.1.2 REVENUE ANALYSIS
13.1.3 PRODUCT PORTFOLIO
13.1.4 RECENT DEVELOPMENTS
13.2 MERCK & CO., INC.
13.2.1 COMPANY SNAPSHOT
13.2.2 REVENUE ANALYSIS
13.2.3 PRODUCT PORTFOLIO
13.2.4 RECENT DEVELOPMENTS
13.3 SANOFI
13.3.1 COMPANY SNAPSHOT
13.3.2 REVENUE ANALYSIS
13.3.3 PRODUCT PORTFOLIO
13.3.4 RECENT DEVELOPMENTS
13.4 BOEHRINGER INGELHEIM INTERNATIONAL GMBH
13.4.1 COMPANY SNAPSHOT
13.4.2 PRODUCT PORTFOLIO
13.4.3 RECENT DEVELOPMENT
13.5 CEVA SANTÉ ANIMALE
13.5.1 COMPANY SNAPSHOT
13.5.2 PRODUCT PORTFOLIO
13.5.3 RECENT DEVELOPMENT
13.6 BIOGENESIS BAGO SA
13.6.1 COMPANY SNAPSHOT
13.6.2 PRODUCT PORTFOLIO
13.6.3 RECENT DEVELOPMENT
13.7 HESTER BIOSCIENCES LTD
13.7.1 COMPANY SNAPSHOT
13.7.2 REVENUE ANALYSIS
13.7.3 PRODUCT PORTFOLIO
13.7.4 RECENT DEVELOPMENT
13.8 M.C.I. SANTÉ ANIMALE
13.8.1 COMPANY SNAPSHOT
13.8.2 PRODUCT PORTFOLIO
13.8.3 RECENT DEVELOPMENT
13.9 ONDERSTEPOORT BIOLOGICAL PRODUCTS SOC (PYT) LTD
13.9.1 COMPANY SNAPSHOT
13.9.2 PRODUCT PORTFOLIO
13.9.3 RECENT DEVELOPMENTS
14 QUESTIONNAIRE
15 RELATED REPORTS
表のリスト
TABLE 1 VACCINES UNDER CLINICAL TRIAL
TABLE 2 THE SIDE EFFECTS RELATED TO VACCINES
TABLE 3 MIDDLE EAST AND AFRICA ANIMAL AND HUMAN VACCINES MARKET, BY TYPE 2022-2031 (USD THOUSAND)
TABLE 4 MIDDLE EAST AND AFRICA HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 5 MIDDLE EAST AND AFRICA HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)
TABLE 6 MIDDLE EAST AND AFRICA ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 7 MIDDLE EAST AND AFRICA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 8 MIDDLE EAST AND AFRICA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 9 MIDDLE EAST AND AFRICA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 10 MIDDLE EAST AND AFRICA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
THE AFRICAN HORSE SICKNESS SEGMENT IS FURTHER SUB-SEGMENTED BY TYPE INTO LIVE AND INACTIVATED. 92
TABLE 11 MIDDLE EAST AND AFRICA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 12 MIDDLE EAST AND AFRICA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 13 MIDDLE EAST AND AFRICA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 14 MIDDLE EAST AND AFRICA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 15 MIDDLE EAST AND AFRICA ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 16 MIDDLE EAST AND AFRICA HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 17 MIDDLE EAST AND AFRICA CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 18 MIDDLE EAST AND AFRICA OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 19 MIDDLE EAST AND AFRICA ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 20 MIDDLE EAST ANIMAL AND HUMAN VACCINES MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)
TABLE 21 MIDDLE EAST ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)
TABLE 22 MIDDLE EAST HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 23 MIDDLE EAST HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)
TABLE 24 MIDDLE EAST ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 25 MIDDLE EAST BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 26 MIDDLE EAST BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 27 MIDDLE EAST FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 28 MIDDLE EAST FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 29 MIDDLE EAST AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 30 MIDDLE EAST AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 31 MIDDLE EAST RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 32 MIDDLE EAST RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 33 MIDDLE EAST ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 34 MIDDLE EAST HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 35 MIDDLE EAST CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 36 MIDDLE EAST OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 37 MIDDLE EAST ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 38 SAUDI ARABIA ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)
TABLE 39 SAUDI ARABIA HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 40 SAUDI ARABIA HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)
TABLE 41 SAUDI ARABIA ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 42 SAUDI ARABIA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 43 SAUDI ARABIA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 44 SAUDI ARABIA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 45 SAUDI ARABIA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 46 SAUDI ARABIA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 47 SAUDI ARABIA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 48 SAUDI ARABIA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 49 SAUDI ARABIA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 50 SAUDI ARABIA ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 51 SAUDI ARABIA HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 52 SAUDI ARABIA CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 53 SAUDI ARABIA OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 54 SAUDI ARABIA ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 55 EGYPT ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)
TABLE 56 EGYPT HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 57 EGYPT HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)
TABLE 58 EGYPT ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 59 EGYPT BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 60 EGYPT BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 61 EGYPT FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 62 EGYPT FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 63 EGYPT AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 64 EGYPT AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 65 EGYPT RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 66 EGYPT RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 67 EGYPT ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 68 EGYPT HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 69 EGYPT CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 70 EGYPT OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 71 EGYPT ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 72 U.A.E. ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)
TABLE 73 U.A.E. HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 74 U.A.E. HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)
TABLE 75 U.A.E. ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 76 U.A.E. BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 77 U.A.E. BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 78 U.A.E. FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 79 U.A.E. FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 80 U.A.E. AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 81 U.A.E. AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 82 U.A.E. RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 83 U.A.E. RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 84 U.A.E. ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 85 U.A.E. HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 86 U.A.E. CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 87 U.A.E. OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 88 U.A.E. ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 89 ISRAEL ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)
TABLE 90 ISRAEL HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 91 ISRAEL HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)
TABLE 92 ISRAEL ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 93 ISRAEL BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 94 ISRAEL BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 95 ISRAEL FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 96 ISRAEL FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 97 ISRAEL AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 98 ISRAEL AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 99 ISRAEL RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 100 ISRAEL RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 101 ISRAEL ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 102 ISRAEL HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 103 ISRAEL CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 104 ISRAEL OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 105 ISRAEL ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 106 IRAN ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)
TABLE 107 IRAN HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 108 IRAN HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)
TABLE 109 IRAN ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 110 IRAN BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 111 IRAN BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 112 IRAN FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 113 IRAN FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 114 IRAN AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 115 IRAN AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 116 IRAN RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 117 IRAN RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 118 IRAN ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 119 IRAN HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 120 IRAN CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 121 IRAN OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 122 IRAN ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 123 IRAQ ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)
TABLE 124 IRAQ HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 125 IRAQ HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)
TABLE 126 IRAQ ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 127 IRAQ BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 128 IRAQ BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 129 IRAQ FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 130 IRAQ FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 131 IRAQ AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 132 IRAQ AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 133 IRAQ RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 134 IRAQ RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 135 IRAQ ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 136 IRAQ HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 137 IRAQ CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 138 IRAQ OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 139 IRAQ ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 140 OMAN ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)
TABLE 141 OMAN HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 142 OMAN HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)
TABLE 143 OMAN ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 144 OMAN BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 145 OMAN BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 146 OMAN FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 147 OMAN FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 148 OMAN AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 149 OMAN AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 150 OMAN RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 151 OMAN RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 152 OMAN ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 153 OMAN HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 154 OMAN CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 155 OMAN OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 156 OMAN ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 157 KUWAIT ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)
TABLE 158 KUWAIT HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 159 KUWAIT HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)
TABLE 160 KUWAIT ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 161 KUWAIT BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 162 KUWAIT BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 163 KUWAIT FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 164 KUWAIT FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 165 KUWAIT AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 166 KUWAIT AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 167 KUWAIT RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 168 KUWAIT RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 169 KUWAIT ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 170 KUWAIT HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 171 KUWAIT CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 172 KUWAIT OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 173 KUWAIT ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 174 QATAR ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)
TABLE 175 QATAR HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 176 QATAR HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)
TABLE 177 QATAR ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 178 QATAR BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 179 QATAR BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 180 QATAR FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 181 QATAR FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 182 QATAR AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 183 QATAR AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 184 QATAR RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 185 QATAR RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 186 QATAR ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 187 QATAR HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 188 QATAR CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 189 QATAR OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 190 QATAR ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 191 BAHRAIN ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)
TABLE 192 BAHRAIN HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 193 BAHRAIN HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)
TABLE 194 BAHRAIN ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 195 BAHRAIN BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 196 BAHRAIN BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 197 BAHRAIN FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 198 BAHRAIN FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 199 BAHRAIN AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 200 BAHRAIN AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 201 BAHRAIN RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 202 BAHRAIN RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 203 BAHRAIN ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 204 BAHRAIN HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 205 BAHRAIN CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 206 BAHRAIN OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 207 BAHRAIN ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 208 YEMEN ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)
TABLE 209 YEMEN HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 210 YEMEN HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)
TABLE 211 YEMEN ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 212 YEMEN BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 213 YEMEN BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 214 YEMEN FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 215 YEMEN FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 216 YEMEN AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 217 YEMEN AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 218 YEMEN RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 219 YEMEN RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 220 YEMEN ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 221 YEMEN HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 222 YEMEN CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 223 YEMEN OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 224 YEMEN ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 225 JORDAN ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)
TABLE 226 JORDAN HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 227 JORDAN HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)
TABLE 228 JORDAN ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 229 JORDAN BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 230 JORDAN BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 231 JORDAN FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 232 JORDAN FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 233 JORDAN AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 234 JORDAN AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 235 JORDAN RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 236 JORDAN RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 237 JORDAN ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 238 JORDAN HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 239 JORDAN CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 240 JORDAN OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 241 JORDAN ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 242 LEBANON ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)
TABLE 243 LEBANON HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 244 LEBANON HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)
TABLE 245 LEBANON ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 246 LEBANON BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 247 LEBANON BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 248 LEBANON FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 249 LEBANON FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 250 LEBANON AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 251 LEBANON AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 252 LEBANON RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 253 LEBANON RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 254 LEBANON ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 255 LEBANON HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 256 LEBANON CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 257 LEBANON OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 258 LEBANON ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 259 PALESTINE ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)
TABLE 260 PALESTINE HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 261 PALESTINE HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)
TABLE 262 PALESTINE ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 263 PALESTINE BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 264 PALESTINE BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 265 PALESTINE FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 266 PALESTINE FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 267 PALESTINE AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 268 PALESTINE AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 269 PALESTINE RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 270 PALESTINE RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 271 PALESTINE ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 272 PALESTINE HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 273 PALESTINE CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 274 PALESTINE OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 275 PALESTINE ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 276 REST OF MIDDLE EAST ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)
TABLE 277 AFRICA ANIMAL AND HUMAN VACCINES MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)
TABLE 278 AFRICA ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)
TABLE 279 AFRICA HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 280 AFRICA HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)
TABLE 281 AFRICA ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 282 AFRICA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 283 AFRICA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 284 AFRICA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 285 AFRICA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 286 AFRICA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 287 AFRICA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 288 AFRICA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 289 AFRICA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 290 AFRICA ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 291 AFRICA HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 292 AFRICA CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 293 AFRICA OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 294 AFRICA ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 295 SOUTH AFRICA ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)
TABLE 296 SOUTH AFRICA HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 297 SOUTH AFRICA HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)
TABLE 298 SOUTH AFRICA ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 299 SOUTH AFRICA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 300 SOUTH AFRICA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 301 SOUTH AFRICA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 302 SOUTH AFRICA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 303 SOUTH AFRICA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 304 SOUTH AFRICA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 305 SOUTH AFRICA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 306 SOUTH AFRICA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 307 SOUTH AFRICA ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 308 SOUTH AFRICA HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 309 SOUTH AFRICA CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 310 SOUTH AFRICA OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 311 SOUTH AFRICA ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 312 NIGERIA ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)
TABLE 313 NIGERIA HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 314 NIGERIA HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)
TABLE 315 NIGERIA ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 316 NIGERIA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 317 NIGERIA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 318 NIGERIA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 319 NIGERIA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 320 NIGERIA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 321 NIGERIA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 322 NIGERIA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 323 NIGERIA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 324 NIGERIA ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 325 NIGERIA HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 326 NIGERIA CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 327 NIGERIA OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 328 NIGERIA ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 329 ETHIOPIA ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)
TABLE 330 ETHIOPIA HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 331 ETHIOPIA HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)
TABLE 332 ETHIOPIA ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 333 ETHIOPIA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 334 ETHIOPIA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 335 ETHIOPIA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 336 ETHIOPIA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 337 ETHIOPIA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 338 ETHIOPIA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 339 ETHIOPIA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 340 ETHIOPIA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 341 ETHIOPIA ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 342 ETHIOPIA HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 343 ETHIOPIA CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 344 ETHIOPIA OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 345 ETHIOPIA ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 346 TANZANIA ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)
TABLE 347 TANZANIA HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 348 TANZANIA HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)
TABLE 349 TANZANIA ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 350 TANZANIA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 351 TANZANIA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 352 TANZANIA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 353 TANZANIA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 354 TANZANIA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 355 TANZANIA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 356 TANZANIA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 357 TANZANIA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 358 TANZANIA ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 359 TANZANIA HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 360 TANZANIA CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 361 TANZANIA OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 362 TANZANIA ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 363 KENYA ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)
TABLE 364 KENYA HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 365 KENYA HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)
TABLE 366 KENYA ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 367 KENYA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 368 KENYA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 369 KENYA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 370 KENYA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 371 KENYA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 372 KENYA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 373 KENYA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 374 KENYA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 375 KENYA ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 376 KENYA HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 377 KENYA CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 378 KENYA OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 379 KENYA ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 380 ALGERIA ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)
TABLE 381 ALGERIA HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 382 ALGERIA HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)
TABLE 383 ALGERIA ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 384 ALGERIA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 385 ALGERIA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 386 ALGERIA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 387 ALGERIA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 388 ALGERIA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 389 ALGERIA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 390 ALGERIA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 391 ALGERIA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 392 ALGERIA ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 393 ALGERIA HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 394 ALGERIA CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 395 ALGERIA OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 396 ALGERIA ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 397 GHANA ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)
TABLE 398 GHANA HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 399 GHANA HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)
TABLE 400 GHANA ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 401 GHANA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 402 GHANA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 403 GHANA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 404 GHANA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 405 GHANA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 406 GHANA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 407 GHANA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 408 GHANA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 409 GHANA ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 410 GHANA HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 411 GHANA CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 412 GHANA OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 413 GHANA ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 414 MOZAMBIQUE ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)
TABLE 415 MOZAMBIQUE HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 416 MOZAMBIQUE HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)
TABLE 417 MOZAMBIQUE ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 418 MOZAMBIQUE BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 419 MOZAMBIQUE BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 420 MOZAMBIQUE FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 421 MOZAMBIQUE FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 422 MOZAMBIQUE AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 423 MOZAMBIQUE AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 424 MOZAMBIQUE RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 425 MOZAMBIQUE RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 426 MOZAMBIQUE ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 427 MOZAMBIQUE HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 428 MOZAMBIQUE CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 429 MOZAMBIQUE OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 430 MOZAMBIQUE ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 431 UGANDA ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)
TABLE 432 UGANDA HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 433 UGANDA HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)
TABLE 434 UGANDA ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 435 UGANDA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 436 UGANDA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 437 UGANDA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 438 UGANDA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 439 UGANDA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 440 UGANDA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 441 UGANDA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 442 UGANDA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 443 UGANDA ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 444 UGANDA HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 445 UGANDA CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 446 UGANDA OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 447 UGANDA ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 448 DEMOCRATIC REPUBLIC OF CONGO ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)
TABLE 449 DEMOCRATIC REPUBLIC OF CONGO HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 450 DEMOCRATIC REPUBLIC OF CONGO HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)
TABLE 451 DEMOCRATIC REPUBLIC OF CONGO ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 452 DEMOCRATIC REPUBLIC OF CONGO BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 453 DEMOCRATIC REPUBLIC OF CONGO BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 454 DEMOCRATIC REPUBLIC OF CONGO FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 455 DEMOCRATIC REPUBLIC OF CONGO FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 456 DEMOCRATIC REPUBLIC OF CONGO AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 457 DEMOCRATIC REPUBLIC OF CONGO AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 458 DEMOCRATIC REPUBLIC OF CONGO RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 459 DEMOCRATIC REPUBLIC OF CONGO RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 460 DEMOCRATIC REPUBLIC OF CONGO ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 461 DEMOCRATIC REPUBLIC OF CONGO HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 462 DEMOCRATIC REPUBLIC OF CONGO CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 463 DEMOCRATIC REPUBLIC OF CONGO OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 464 DEMOCRATIC REPUBLIC OF CONGO ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 465 SUDAN ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)
TABLE 466 SUDAN HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 467 SUDAN HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)
TABLE 468 SUDAN ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 469 SUDAN BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 470 SUDAN BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 471 SUDAN FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 472 SUDAN FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 473 SUDAN AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 474 SUDAN AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 475 SUDAN RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 476 SUDAN RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 477 SUDAN ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 478 SUDAN HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 479 SUDAN CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 480 SUDAN OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 481 SUDAN ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 482 MOROCCO ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)
TABLE 483 MOROCCO HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 484 MOROCCO HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)
TABLE 485 MOROCCO ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 486 MOROCCO BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 487 MOROCCO BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 488 MOROCCO FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 489 MOROCCO FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 490 MOROCCO AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 491 MOROCCO AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 492 MOROCCO RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 493 MOROCCO RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 494 MOROCCO ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 495 MOROCCO HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 496 MOROCCO CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 497 MOROCCO OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 498 MOROCCO ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 499 ANGOLA ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)
TABLE 500 ANGOLA HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 501 ANGOLA HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)
TABLE 502 ANGOLA ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 503 ANGOLA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 504 ANGOLA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 505 ANGOLA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 506 ANGOLA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 507 ANGOLA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 508 ANGOLA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 509 ANGOLA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 510 ANGOLA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 511 ANGOLA ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 512 ANGOLA HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 513 ANGOLA CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 514 ANGOLA OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 515 ANGOLA ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 516 MADAGASCAR ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)
TABLE 517 MADAGASCAR HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 518 MADAGASCAR HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)
TABLE 519 MADAGASCAR ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 520 MADAGASCAR BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 521 MADAGASCAR BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 522 MADAGASCAR FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 523 MADAGASCAR FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 524 MADAGASCAR AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 525 MADAGASCAR AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 526 MADAGASCAR RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 527 MADAGASCAR RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 528 MADAGASCAR ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 529 MADAGASCAR HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 530 MADAGASCAR CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 531 MADAGASCAR OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 532 MADAGASCAR ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 533 MALAWI ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)
TABLE 534 MALAWI HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 535 MALAWI HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)
TABLE 536 MALAWI ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 537 MALAWI BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 538 MALAWI BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 539 MALAWI FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 540 MALAWI FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 541 MALAWI AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 542 MALAWI AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 543 MALAWI RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 544 MALAWI RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 545 MALAWI ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 546 MALAWI HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 547 MALAWI CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 548 MALAWI OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 549 MALAWI ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 550 ZAMBIA ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)
TABLE 551 ZAMBIA HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 552 ZAMBIA HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)
TABLE 553 ZAMBIA ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 554 ZAMBIA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 555 ZAMBIA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 556 ZAMBIA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 557 ZAMBIA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 558 ZAMBIA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 559 ZAMBIA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 560 ZAMBIA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 561 ZAMBIA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 562 ZAMBIA ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 563 ZAMBIA HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 564 ZAMBIA CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 565 ZAMBIA OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 566 ZAMBIA ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 567 IVORY COAST ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)
TABLE 568 IVORY COAST HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 569 IVORY COAST HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)
TABLE 570 IVORY COAST ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 571 IVORY COAST BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 572 IVORY COAST BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 573 IVORY COAST FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 574 IVORY COAST FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 575 IVORY COAST AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 576 IVORY COAST AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 577 IVORY COAST RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 578 IVORY COAST RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 579 IVORY COAST ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 580 IVORY COAST HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 581 IVORY COAST CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 582 IVORY COAST OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 583 IVORY COAST ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 584 CAMEROON ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)
TABLE 585 CAMEROON HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 586 CAMEROON HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)
TABLE 587 CAMEROON ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 588 CAMEROON BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 589 CAMEROON BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 590 CAMEROON FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 591 CAMEROON FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 592 CAMEROON AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 593 CAMEROON AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 594 CAMEROON RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 595 CAMEROON RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 596 CAMEROON ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 597 CAMEROON HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 598 CAMEROON CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 599 CAMEROON OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 600 CAMEROON ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 601 ZIMBABWE ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)
TABLE 602 ZIMBABWE HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 603 ZIMBABWE HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)
TABLE 604 ZIMBABWE ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 605 ZIMBABWE BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 606 ZIMBABWE BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 607 ZIMBABWE FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 608 ZIMBABWE FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 609 ZIMBABWE AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 610 ZIMBABWE AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 611 ZIMBABWE RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 612 ZIMBABWE RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 613 ZIMBABWE ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 614 ZIMBABWE HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 615 ZIMBABWE CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 616 ZIMBABWE OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 617 ZIMBABWE ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 618 LIBYA ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)
TABLE 619 LIBYA HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 620 LIBYA HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)
TABLE 621 LIBYA ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 622 LIBYA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 623 LIBYA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 624 LIBYA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 625 LIBYA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 626 LIBYA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 627 LIBYA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 628 LIBYA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 629 LIBYA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 630 LIBYA ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 631 LIBYA HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 632 LIBYA CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 633 LIBYA CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 634 LIBYA ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 635 CHAD ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)
TABLE 636 CHAD HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 637 CHAD HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)
TABLE 638 CHAD ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 639 CHAD BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 640 CHAD BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 641 CHAD FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 642 CHAD FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 643 CHAD AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 644 CHAD AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 645 CHAD RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 646 CHAD RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 647 CHAD ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 648 CHAD HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 649 CHAD CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 650 CHAD OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 651 CHAD ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 652 BOTSWANA ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)
TABLE 653 BOTSWANA HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 654 BOTSWANA HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)
TABLE 655 BOTSWANA ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 656 BOTSWANA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 657 BOTSWANA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 658 BOTSWANA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 659 BOTSWANA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 660 BOTSWANA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 661 BOTSWANA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 662 BOTSWANA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 663 BOTSWANA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 664 BOTSWANA ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 665 BOTSWANA HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 666 BOTSWANA CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 667 BOTSWANA OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 668 BOTSWANA ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 669 NAMIBIA ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)
TABLE 670 NAMIBIA HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 671 NAMIBIA HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)
TABLE 672 NAMIBIA ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 673 NAMIBIA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 674 NAMIBIA BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 675 NAMIBIA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 676 NAMIBIA FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 677 NAMIBIA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 678 NAMIBIA AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 679 NAMIBIA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 680 NAMIBIA RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 681 NAMIBIA ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 682 NAMIBIA HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 683 NAMIBIA CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 684 NAMIBIA OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 685 NAMIBIA ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 686 LESOTHO ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)
TABLE 687 LESOTHO HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 688 LESOTHO HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)
TABLE 689 LESOTHO ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 690 LESOTHO BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 691 LESOTHO BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 692 LESOTHO FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 693 LESOTHO FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 694 LESOTHO AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 695 LESOTHO AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 696 LESOTHO RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 697 LESOTHO RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 698 LESOTHO ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 699 LESOTHO HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 700 LESOTHO CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 701 LESOTHO OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 702 LESOTHO ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 703 MAURITIUS ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)
TABLE 704 MAURITIUS HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 705 MAURITIUS HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)
TABLE 706 MAURITIUS ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 707 MAURITIUS BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 708 MAURITIUS BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 709 MAURITIUS FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 710 MAURITIUS FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 711 MAURITIUS AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 712 MAURITIUS AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 713 MAURITIUS RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 714 MAURITIUS RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 715 MAURITIUS ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 716 MAURITIUS HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 717 MAURITIUS CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 718 MAURITIUS OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 719 MAURITIUS ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 720 ESWATINI ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)
TABLE 721 ESWATINI HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 722 ESWATINI HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)
TABLE 723 ESWATINI ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 724 ESWATINI BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 725 ESWATINI BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 726 ESWATINI FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 727 ESWATINI FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 728 ESWATINI AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 729 ESWATINI AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 730 ESWATINI RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 731 ESWATINI RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 732 ESWATINI ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 733 ESWATINI HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 734 ESWATINI CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 735 ESWATINI OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 736 ESWATINI ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 737 COMOROS ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)
TABLE 738 COMOROS HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 739 COMOROS HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)
TABLE 740 COMOROS ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 741 COMOROS BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 742 COMOROS BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 743 COMOROS FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 744 COMOROS FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 745 COMOROS AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 746 COMOROS AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 747 COMOROS RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 748 COMOROS RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 749 COMOROS ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 750 COMOROS HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 751 COMOROS CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 752 COMOROS OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 753 COMOROS ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 754 SEYCHELLES ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)
TABLE 755 SEYCHELLES HUMAN IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 756 SEYCHELLES HUMAN PAPILLOMAVIRUS (HPV) IN ANIMAL AND HUMAN VACCINES MARKET, BY DISEASE INDICATION, 2022-2031 (USD THOUSAND)
TABLE 757 SEYCHELLES ANIMAL IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 758 SEYCHELLES BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 759 SEYCHELLES BRUCELLOSIS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 760 SEYCHELLES FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 761 SEYCHELLES FOOT AND MOUTH IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 762 SEYCHELLES AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 763 SEYCHELLES AFRICAN HORSE SICKNESS IN ANIMAL AND HUMAN VACCINES MARKET, BY ANIMAL, 2022-2031 (USD THOUSAND)
TABLE 764 SEYCHELLES RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 765 SEYCHELLES RIFT VALLEY FEVER IN ANIMAL AND HUMAN VACCINES MARKET, BY VACCINE TYPE, 2022-2031 (USD THOUSAND)
TABLE 766 SEYCHELLES ANIMAL AND HUMAN VACCINES MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 767 SEYCHELLES HOSPITALS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 768 SEYCHELLES CLINICS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 769 SEYCHELLES OTHERS IN ANIMAL AND HUMAN VACCINES MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 770 SEYCHELLES ANIMAL AND HUMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 771 REST OF AFRICA ANIMAL AND HUMAN VACCINES MARKET, TYPE, 2022-2031 (USD THOUSAND)
図表一覧
FIGURE 1 INDIA AND EUROPE GENERIC INJECTABLES MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST AND AFRICA ANIMAL AND HUMAN VACCINES MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST AND AFRICA ANIMAL AND HUMAN VACCINES MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST AND AFRICA ANIMAL AND HUMAN VACCINES MARKET: REGIONAL VS COUNTRY MARKET ANALYSIS
FIGURE 5 MIDDLE EAST AND AFRICA ANIMAL AND HUMAN VACCINES MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST AND AFRICA ANIMAL AND HUMAN VACCINES MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 MIDDLE EAST AND AFRICA ANIMAL AND HUMAN VACCINES MARKET: DBMR MARKET POSITION GRID
FIGURE 8 MIDDLE EAST AND AFRICA ANIMAL AND HUMAN VACCINES MARKET: VENDOR SHARE ANALYSIS
FIGURE 9 MIDDLE EAST AND AFRICA ANIMAL AND HUMAN VACCINES MARKET: SEGMENTATION
FIGURE 10 ESCALATING INCIDENCE OF CHRONIC DISEASES AND SURGE IN THE DEVELOPMENT AND PRODUCTION OF VACCINES ARE DRIVING THE GROWTH OF THE MIDDLE EAST AND AFRICA ANIMAL AND HUMAN VACCINES MARKET IN THE FORECAST PERIOD OF 2024 TO 2031
FIGURE 11 TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA ANIMAL AND HUMAN VACCINES MARKET IN 2024 AND 2031
FIGURE 12 OPPORTUNITIES, AND CHALLENGES OF THE MIDDLE EAST AND AFRICA ANIMAL AND HUMAN VACCINES MARKET
FIGURE 13 MIDDLE EAST AND AFRICA ANIMAL AND HUMAN VACCINES MARKET: BY TYPE, 2023
FIGURE 14 MIDDLE EAST AND AFRICA ANIMAL AND HUMAN VACCINES MARKET: BY TYPE, 2024-2031 (USD THOUSAND)
FIGURE 15 MIDDLE EAST AND AFRICA ANIMAL AND HUMAN VACCINES MARKET: BY TYPE, CAGR (2024-2031)
FIGURE 16 MIDDLE EAST AND AFRICA ANIMAL AND HUMAN VACCINES MARKET: BY TYPE, LIFELINE CURVE
FIGURE 17 MIDDLE EAST AND AFRICA ANIMAL AND HUMAN VACCINES MARKET: BY END USER, 2023
FIGURE 18 MIDDLE EAST AND AFRICA ANIMAL AND HUMAN VACCINES MARKET: BY END USER, 2024-2031 (USD THOUSAND)
FIGURE 19 MIDDLE EAST AND AFRICA ANIMAL AND HUMAN VACCINES MARKET: BY END USER, CAGR (2024-2031)
FIGURE 20 MIDDLE EAST AND AFRICA ANIMAL AND HUMAN VACCINES MARKET: BY END USER, LIFELINE CURVE
FIGURE 21 MIDDLE EAST AND AFRICA ANIMAL AND HUMAN VACCINES MARKET: BY DISTRIBUTION CHANNEL, 2023
FIGURE 22 MIDDLE EAST AND AFRICA ANIMAL AND HUMAN VACCINES MARKET: BY DISTRIBUTION CHANNEL, 2024-2031 (USD THOUSAND)
FIGURE 23 MIDDLE EAST AND AFRICA ANIMAL AND HUMAN VACCINES MARKET: BY DISTRIBUTION CHANNEL, CAGR (2024-2031)
FIGURE 24 MIDDLE EAST AND AFRICA ANIMAL AND HUMAN VACCINES MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 25 MIDDLE EAST &AFRICA ANIMAL AND HUMAN VACCINES MARKET: SNAPSHOT (2023)
FIGURE 26 MIDDLE EAST ANIMAL AND HUMAN VACCINES MARKET: SNAPSHOT (2023)
FIGURE 27 AFRICA ANIMAL AND HUMAN VACCINES MARKET: SNAPSHOT (2023)
FIGURE 28 MIDDLE EAST AND AFRICA ANIMAL AND HUMAN VACCINES MARKET: COMPANY SHARE 2023 (%)
調査方法
データ収集と基準年分析は、大規模なサンプル サイズのデータ収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。
DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。
カスタマイズ可能
Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータ スタイルでいくつでも追加できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクト ブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。